TOMMASI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 248
NA - Nord America 186
AS - Asia 77
Totale 511
Nazione #
US - Stati Uniti d'America 186
IE - Irlanda 87
IT - Italia 75
CN - Cina 58
SE - Svezia 35
SG - Singapore 17
AT - Austria 15
DE - Germania 8
FI - Finlandia 7
ES - Italia 5
BE - Belgio 4
CZ - Repubblica Ceca 4
PL - Polonia 3
PT - Portogallo 2
FR - Francia 1
GB - Regno Unito 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
Totale 511
Città #
Dublin 87
Chandler 57
Shanghai 34
Ashburn 30
Parma 21
Beijing 17
Vienna 15
New York 14
Singapore 11
Bologna 9
Boardman 7
Ravenna 7
Bremen 6
Milan 6
Princeton 6
Seattle 6
Des Moines 5
Sassuolo 5
Cascina 4
Helsinki 4
Collecchio 3
Reggio Emilia 3
Wilmington 3
Barcelona 2
Brussels 2
Fremont 2
Lisbon 2
Los Angeles 2
Madrid 2
Olomouc 2
Scarperia e San Piero 2
Torrile 2
Woodbridge 2
Amsterdam 1
Ann Arbor 1
Corno di Rosazzo 1
Fairfield 1
Gambettola 1
Hangzhou 1
Hong Kong 1
Leuven 1
London 1
Miami 1
Modena 1
Molenbeek-Saint-Jean 1
Piacenza 1
Prague 1
Redmond 1
Rio Saliceto 1
Roseland 1
Sassari 1
Shenzhen 1
Taglio Di Po 1
Tokyo 1
Trieste 1
Totale 402
Nome #
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 50
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 50
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 49
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 46
A review of immune checkpoint blockade in breast cancer 39
A narrative review of the principal glucocorticoids employed in cancer 36
My best choice after a round trip from illness 35
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma 33
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 28
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 27
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 24
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 23
The Innate Immune Microenvironment in Metastatic Breast Cancer 23
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 21
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 15
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 10
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 9
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study 6
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 5
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 5
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report 5
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals 4
Totale 543
Categoria #
all - tutte 3.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.044


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 13 0 0
2021/202244 0 0 5 6 4 4 7 2 0 1 0 15
2022/2023262 22 18 17 14 37 27 3 14 88 2 15 5
2023/2024212 7 29 3 3 14 35 23 14 12 26 21 25
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 543